It’s a day by day battle. Diagnosed with #Crohns o

It’s a day by day battle. Diagnosed with #Crohns or #colitis? Click below and join MyCrohnsAndColitisTeam to share… https://t.co/2qsabomc2n

I’ve noticed we’ve hit a ceiling in terms of what

I’ve noticed we’ve hit a ceiling in terms of what is currently available to “treat” #crohnsdisease, current treatme… https://t.co/hdRGKx2O0s

It seems we are on an etiology path for #crohnsdisease is multifactorial. If that is the case, then we need multi-d… https://t.co/pwD3JqCBi2

@LeeLee2873 Check out the biosimilars section here: https://t.co/lBP5m37xy6

Biosimilars are the generics for biolo… https://t.co/w3vOAxNIcs

Finding a solution IS POSSIBLE. But, it will mean uncomfortable discussions and accountability about our environmen… https://t.co/dPzBEkpjHP

@POTUS Then allow us to buy biosimilars from other countries!!!

Daily Updates on Generic Entry, Litigation, Biosimilars, and more with the DrugPatentWatch Daily Briefing. Sign up… https://t.co/rkqCaf2nTO

FDA scolds Amgen over a misleading ad that could deter use of biosimilar versions of its drug – More stories like t… https://t.co/EIGgEoKr7B

FDA scolds Amgen over a misleading ad that could deter use of biosimilar versions of its drug – More stories like t… https://t.co/eRaWn0ZlEV

In der Schweiz dauert’s i.d.R. etwas länger. 😕 Im Fall der #Biosimilars heisst das: später auf dem Markt und wenn’s… https://t.co/tL1FZDgmuT